2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Arvola P et al. | Exercise enhances vasorelaxation in experimental obesity associated hypertension. | 1999 | Cardiovasc. Res. | pmid:10615427 |
Foudi N et al. | Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. | 2009 | Cardiovasc. Res. | pmid:18952694 |
Wennmalm A et al. | Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. | 1991 | Circulation | pmid:2022025 |
Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |
Roy L et al. | Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. | 1985 | Circulation | pmid:3882264 |
Fitzgerald DJ et al. | Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. | 1987 | Circulation | pmid:3552297 |
RÃ¥ngemark C et al. | Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. | 1992 | Circulation | pmid:1423963 |
Fitzgerald DJ et al. | The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. | 1984 | Circulation | pmid:6428771 |
Adatia I et al. | Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. | 1993 | Circulation | pmid:8222105 |
Belton O et al. | Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. | 2000 | Circulation | pmid:10952950 |
Brown NJ et al. | Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. | 2000 | Circulation | pmid:11056091 |
Capone ML et al. | Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. | 2004 | Circulation | pmid:15037526 |
Wennmalm A et al. | Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. | 1988 | Clin Physiol | pmid:3402185 |
Wennmalm A | Formation of prostacyclin during administration of beta 1-selective and non-selective beta-adrenergic antagonists in healthy humans. | 1992 | Clin Physiol | pmid:1347260 |
Wennmalm A et al. | Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. | 1993 | Clin Physiol | pmid:8519161 |
Cibattoni G et al. | Effects of sulindac on renal and extrarenal eicosanoid synthesis. | 1987 | Clin. Pharmacol. Ther. | pmid:3549118 |
Skarke C et al. | Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. | 2012 | Clin. Pharmacol. Ther. | pmid:22278334 |
Wennmalm A et al. | Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. | 1990 | Clin. Sci. | pmid:2176952 |
Watson ML et al. | Urinary kallikrein and systemic prostacyclin synthesis during sodium chloride infusion in normal man. | 1985 | Clin. Sci. | pmid:3884237 |
Wennmalm A et al. | 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion. | 1992 | Clin. Sci. | pmid:1330409 |
RÃ¥ngemark C and Wennmalm A | Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. | 1991 | Clin. Sci. | pmid:1649717 |
Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |
Watson ML et al. | Prostaglandins and kallikrein during volume expansion in normal man. | 1984 | Contrib Nephrol | pmid:6570094 |
Rautanen M et al. | Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. | 1997 | Crit. Care Med. | pmid:9233750 |
Koivisto VA et al. | Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. | 1989 | Diabetes Care | pmid:2507264 |
Closa D et al. | Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. | 1993 | Dig. Dis. Sci. | pmid:7678383 |
Ross S et al. | Association of cyclooxygenase-2 genetic variant with cardiovascular disease. | 2014 | Eur. Heart J. | pmid:24796340 |
Lahoz C et al. | Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. | 1997 | Eur. J. Clin. Invest. | pmid:9352251 |
Vesterqvist O and Gréen K | Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man. | 1989 | Eur. J. Clin. Pharmacol. | pmid:2515064 |
Vesterqvist O | Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. | 1986 | Eur. J. Clin. Pharmacol. | pmid:3519239 |
Larsson PT et al. | Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation. | 1992 | Eur. J. Clin. Pharmacol. | pmid:1387607 |
Edlund A et al. | Acipimox stimulates skin blood flow by a cyclo-oxygenase-dependent mechanism. | 1990 | Eur. J. Clin. Pharmacol. | pmid:2125938 |
Greer IA et al. | Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation. | 1990 May-Jun | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:1970789 |
Watson ML et al. | Systemic synthesis of prostaglandin I2 following sustained infusion of angiotensin II in conscious dogs. | 1986 | Eur. J. Pharmacol. | pmid:3530786 |
Guarner F et al. | Increased synthesis of systemic prostacyclin in cirrhotic patients. | 1986 | Gastroenterology | pmid:3510938 |
Guarner C et al. | Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. | 1992 | Gastroenterology | pmid:1727763 |
Martineau A et al. | Defective synthesis of vasodilator prostaglandins in the spontaneously hypertensive rat. | 1984 Mar-Apr | Hypertension | pmid:6373595 |
Falardeau P and Martineau A | In vivo production of prostaglandin I2 in Dahl salt-sensitive and salt-resistant rats. | 1983 Sep-Oct | Hypertension | pmid:6352480 |
Minuz P et al. | Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. | 1988 | Hypertension | pmid:3290103 |
Arnaud J et al. | Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. | 2007 | J Am Coll Nutr | pmid:17914127 |
Tsikas D et al. | Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. | 2000 | J Chromatogr A | pmid:10941682 |
Schwartz JI et al. | Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. | 2007 | J Clin Pharmacol | pmid:17925592 |
Ritter JM et al. | Prostacyclin biosynthesis in essential hypertension before and during treatment. | 1996 | J Hum Hypertens | pmid:8642189 |
Lindström T et al. | The effect of unreamed and reamed intramedullary nailing on the urinary excretion of prostacyclin and thromboxane A2 metabolites in patients with tibial shaft fractures. | 1998 | J Trauma | pmid:9783614 |
Hamm CW et al. | Biochemical evidence of platelet activation in patients with persistent unstable angina. | 1987 | J. Am. Coll. Cardiol. | pmid:3668113 |
Benowitz NL et al. | Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. | 1993 | J. Am. Coll. Cardiol. | pmid:7691912 |
Böger RH et al. | Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin. | 1995 | J. Appl. Physiol. | pmid:7649919 |
Casas J et al. | Determination of 2,3-dinor-6-ketoprostaglandin F1 alpha in urine samples by liquid chromatography and radioimmunoassay. | 1986 | J. Chromatogr. | pmid:3558562 |
Ferretti A and Flanagan VP | Assay of urinary 2,3-dinor-6-oxo prostaglandin F1 alpha by gas chromatography-tandem mass spectrometry. | 1993 | J. Chromatogr. | pmid:8150859 |
Chiabrando C et al. | Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. | 1989 | J. Chromatogr. | pmid:2613794 |